Pharmaceutical - Production, Oncology

Filter

Current filters:

ProductionOncology

Popular Filters

Japan’s Takeda optimizes global production network

27-11-2014

Takeda Pharmaceutical has decided to focus its Osaka plant (Osaka Prefecture, Japan) to become a specialty…

GermanyJapanLupronOncologyPharmaceuticalProductionTakeda Pharmaceutical

MHRA showcases benefit of its industry collaboration with AstraZeneca's Macclesfield plant

MHRA showcases benefit of its industry collaboration with AstraZeneca's Macclesfield plant

27-11-2014

The UK's Medicines and Healthcare products Regulatory Agency has published a case study outlining the…

AstraZenecaOncologyPharmaceuticalProductionUK

Room for new products in metastatic prostate cancer treatment market, says GlobalData

Room for new products in metastatic prostate cancer treatment market, says GlobalData

17-09-2014

Although many new products have been launched since 2010 to treat metastatic castration-resistant prostate…

GlobalDataOncologyPharmaceuticalProductionResearchXtandiZytiga

Compromised vials of Roche's MabThera found in Germany

Compromised vials of Roche's MabThera found in Germany

15-09-2014

Swiss drug major Roche has said that compromised vials of its arthritis and cancer drug MabThera had…

GermanyHerceptinLegalMabTheraOncologyPharmaceuticalProductionRegulationRoche

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

Novartis to start production of Tasigna in Russia

Novartis to start production of Tasigna in Russia

19-08-2014

Russia’s largest drugmaker Pharmstandard has signed an agreement with Swiss pharma major Novartis on…

CancerCytokinesHealth Medical PharmaIgor KrylovMajorNovartisOncologyPharmaceuticalPharmstandardProductionRussiaTasigna

AbbVie to spend $320 million to establish Singapore manufacturing presence

AbbVie to spend $320 million to establish Singapore manufacturing presence

06-02-2014

US drugmaker AbbVie says it plans to invest $320 million to establish operations in Singapore for small…

AbbVieAsia-PacificImmunologicalsOncologyPharmaceuticalProduction

Pharmacyclics signs deal with Lonza to support manufacturing of Imbruvica

Pharmacyclics signs deal with Lonza to support manufacturing of Imbruvica

13-01-2014

USA-based Pharmacyclics has signed a deal with Swiss chemical supplier Lonza for the commercial and clinical…

ImbruvicaLonzaOncologyPharmaceuticalPharmacyclicsProductionUSA

AstraZeneca to invest £120 million in UK site which manufactures Zoladex

AstraZeneca to invest £120 million in UK site which manufactures Zoladex

12-11-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) will invest £120 million in a new facility at its global…

AstraZenecaEuropeOncologyPharmaceuticalProductionUKZoladex

Sagent Pharma debuts Carboplatin Injection

Sagent Pharma debuts Carboplatin Injection

04-11-2013

US specialty drugmaker Sagent Pharmaceuticals has announced the launch of Carboplatin Injection, an antineoplastic…

Asia-PacificCarboplatinMarkets & MarketingNorth AmericaOncologyPharmaceuticalProductionSagent Pharmaceuticals

Bristol-Myers partners with South Korean firm on biopharma production

29-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

Venus gets GMP certifications from Ukraine

22-07-2013

Indian R&D-based drugmaker Venus Remedies (BSE: 526953) has been able to gain a Good Manufacturing Practice…

Antibiotics and Infectious diseasesAsia-PacificEuropeMarkets & MarketingOncologyPharmaceuticalProductionRegulationVenus Remedies

ScinoPharm and Foresee Pharma set up JV for novel oncological peptide drugs

31-01-2013

Taiwanese drugmaker ScinoPharm (TWSE: 1789) and Foresee Pharmaceuticals, a Delaware, USA-based spin-out…

Asia-PacificForesee PharmaceuticalsGenericsleuprolideOncologyPharmaceuticalProductionResearchScinoPharm

Boehringer Ingelheim highlights robust respiratory R&D pipeline; announces investment

01-11-2012

At its 3rd International Research & Development press conference, family-owned German drug major Boehringer…

afatinibBoehringer IngelheimnintedanibolodaterolOncologyPharmaceuticalProductionResearchRespimatRespiratory and Pulmonary

Back to top